Subscribe
shutterstock_1562870302_elnur
Elnur / Shutterstock.com
15 February 2021Big PharmaAlex Baldwin

LSPN Connect: Monetising your IP portfolio

Chances are, if you manage a life sciences portfolio, you had to rethink your monetization strategy last year.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
LSPN Connect: The battle for COVID-19 vaccines
22 June 2021   With the COVID-19 vaccines developed, we are now faced with the monumental task of distributing hundreds of millions of vaccines across the globe.
Biotechnology
LSPN LIVE 2021: an ‘unmissable opportunity’
28 September 2021   Over the past year, the life sciences sector has proved to be of vital importance in the fight against COVID-19. Now more than ever, it is imperative that IP professionals are best positioned to protect and leverage innovation in this fast-paced industry.
Americas
LSPN Live: ‘Unimpressive’ Arthrex remedy fuels uncertainty
7 October 2021   The unpredictable nature of the US legal landscape has arguably kept IP practitioners on tenterhooks over the past decade.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
LSPN Connect: The battle for COVID-19 vaccines
22 June 2021   With the COVID-19 vaccines developed, we are now faced with the monumental task of distributing hundreds of millions of vaccines across the globe.
Biotechnology
LSPN LIVE 2021: an ‘unmissable opportunity’
28 September 2021   Over the past year, the life sciences sector has proved to be of vital importance in the fight against COVID-19. Now more than ever, it is imperative that IP professionals are best positioned to protect and leverage innovation in this fast-paced industry.
Americas
LSPN Live: ‘Unimpressive’ Arthrex remedy fuels uncertainty
7 October 2021   The unpredictable nature of the US legal landscape has arguably kept IP practitioners on tenterhooks over the past decade.

More on this story

Big Pharma
LSPN Connect: The battle for COVID-19 vaccines
22 June 2021   With the COVID-19 vaccines developed, we are now faced with the monumental task of distributing hundreds of millions of vaccines across the globe.
Biotechnology
LSPN LIVE 2021: an ‘unmissable opportunity’
28 September 2021   Over the past year, the life sciences sector has proved to be of vital importance in the fight against COVID-19. Now more than ever, it is imperative that IP professionals are best positioned to protect and leverage innovation in this fast-paced industry.
Americas
LSPN Live: ‘Unimpressive’ Arthrex remedy fuels uncertainty
7 October 2021   The unpredictable nature of the US legal landscape has arguably kept IP practitioners on tenterhooks over the past decade.

More features

President Trump 2.0: Five major areas to watch
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court